# Diagnotes

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/diagnotes

- Industry: Healthcare IT
- Headquarters: Indianapolis, US
- Website: www.diagnotes.com
- Total disclosed funding: $1.2M
- Latest round: Series A (Apr 25, 2013)
- Investors on record: 3

## About

Diagnotes, Inc. is a US-based healthcare technology firm specializing in clinical communication solutions to enhance care coordination and patient engagement across healthcare systems.Founded in 2010 and headquartered in Indianapolis, US, Diagnotes, Inc. operates within the healthcare technology sector, focusing on improving clinical communication. The company has successfully secured a total of USD 1.00 mn in funding across 8 deals, with its most recent funding round being a VENTURE DEBT round of USD 0.25 mn as of February 1, 2023. Diagnotes was acquired in 2023 by DrFirst.com, Inc., a move aimed at strengthening its business and communication capabilities with customers and staff.Backline by DrFirst offers a comprehensive clinical communication platform designed to facilitate seamless and secure communication across healthcare organizations. The core product, Backline, serves as an ecosystem that enables healthcare providers to enhance patient care through improved care coordination, telehealth capabilities, and patient engagement tools. The platform addresses critical use cases such as streamlining workflows for consults and referrals, managing transitions of care, and reducing medical errors. Backline's solutions are utilized by a diverse clientele, including hospitals, medical centers, and healthcare systems across various geographical markets, including the United States and potentially other regions with a focus on organizations looking to innovate in clinical communication and patient care delivery.Backline generates revenue through subscription-based models, providing access to its clinical communication software and associated services. The company collaborates directly with healthcare organizations, establishing B2B partnerships to deliver its solutions tailored to specific client needs. Revenue is derived from various service tiers, offering different functionalities depending on the organization’s requirements and size. The pricing structure encompasses multiple offerings within the Backline ecosystem, which may include flagship products such as Backline+ for enhanced features. These revenue streams contribute to the company's financial stability while supporting ongoing innovation and expansion in healthcare communication solutions.With the recent acquisition by DrFirst.com, Inc., Diagnotes plans to leverage its resources to enhance its product offerings and expand its market presence. The acquisition is expected to support the development of new products designed to improve communication within healthcare settings. Specific geographic markets targeted for expansion include additional regions in the US and potentially international markets by 2024. The funds from the VENTURE DEBT round will be utilized to further develop these initiatives and enhance operational capabilities.

## Funding rounds

- Series A, Apr 25, 2013, $1.2M — BioCrossroads, Innovate Indiana Fund, StepStone Angels

## Investors

- BioCrossroads (https://capitalatlas.ai/funds/biocrossroads) — Series A
- Innovate Indiana Fund — Series A
- StepStone Angels — Series A